At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 40 enrolled
Drug / intervention
saline solutiondrug
Likely dose
saline solution 20 mLfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Dexmedetomidine Compared With Ondansetron in Treating Postanesthetic Shivering in Patients After Regional Anesthesia for Cesarean Section-a Randomized Clinical Trial.
In Brief
A Phase 2 clinical trial evaluating saline solution for Postanesthetic Excitement and Cesarean Section. Completed, enrolled 40 participants across 1 site.
Detailed Summary
Evaluate the efficiency of management with intravenous dexmedetomidine compared to intravenous ondansetron to achieve the disappearance of post-anesthetic shivering in a shorter time in the obstetric patient undergoing cesarean section under regional anesthesia.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPostanesthetic Excitement, Cesarean Section
CountriesMexico
Collaborators--
Timeline
Phase 2CompletedFinished
202120222023202420252026
Enrollment StartAug 2020
Primary CompletionSep 2021
Study CompletionJan 2022
First PostedMar 2024
TodayJul 2026
First PostedMar 1, 2024
Enrollment StartAug 5, 2020
Primary CompletionSep 5, 2021
Study CompletionJan 3, 2022
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 2.3 years ago
Interventions
saline solutiondrug
20 mL of saline